Showing results (1301-1310 of 1,676) with videos related to
Sort By:
Pageof 168
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 19, 2013
22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndromeSara M Sarasua, Alka Dwivedi, Luigi Boccuto, et al.Arthritis Care & Research|November 9, 2020
Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and PerspectivesSusan J Bartlett, Anna Kristina Gutierrez, Kathleen M Andersen, et al.ACR Open Rheumatology|June 11, 2021
Tough Choices: Exploring Medication Decision-Making During Pregnancy and Lactation Among Women With Inflammatory ArthritisMehret Birru Talabi, Amanda M Eudy, Malithi Jayasundara, et al.Rheumatology and Therapy|August 7, 2019
Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USAChristine Radawski, Mark C Genovese, Brett Hauber, et al.Journal of Medicinal Chemistry|January 1, 1991
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotectionP Krogsgaard-Larsen, J W Ferkany, E O Nielsen, et al.Toxicology Letters|January 30, 2014
Bisphenol A regulation of testicular endocrine function in male rats is affected by dietManjunatha K Nanjappa, Manuj Ahuja, Muralikrishnan Dhanasekaran, et al.Diabetes/Metabolism Research and Reviews|February 7, 2015
Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart StudyLana Y H Lai, Andrew B Petrone, James S Pankow, et al.Thrombosis and Haemostasis|January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiologyJacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.ACR Open Rheumatology|December 16, 2021
Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of BaricitinibJanet E Pope, Yvonne C Lee, Jeffrey R Curtis, et al.Pageof 168